[目前治疗心力衰竭,左心室喷射分数略有减少或保留]
Deutsche medizinische Wochenschrift (1946)
|January 29, 2024
概括
新的心力衰竭指南建议SGLT2抑制剂适用于轻微减少或保留射出分数的患者. 对于糖尿病和脏问题的人来说,建议使用费内伦,而铁可以帮助改善特定心力衰竭患者的生活质量.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 最近的临床试验为治疗轻微减少 (HFmrEF) 和保存 (HFpEF) 左心室喷射分数的心力衰竭提供了新的见解.
- 现有的指导方针需要更新,以纳入这些新发现和治疗策略.
研究的目的:
- 总结最新的ESC指南和德国国家心力衰竭疾病管理指南中的关键更新.
- 突出针对特定心力衰竭患者群体的药物治疗和管理策略的新建议.
主要方法:
- 审查和综合最近的临床试验数据.
- 分析欧洲心脏病学会 (ESC) 针对急性和慢性心力衰竭的指导方针.
- 包括来自德国"国家医疗指南" (Nationale Versorgungsleitlinie) 的建议.
主要成果:
- 现在建议SGLT2抑制剂用于患有HFmrEF和HFpEF的患者.
- 费内伦推给糖尿病患者和慢性功能衰竭患者,以减少心力衰竭住院的风险.
- 对于患有HFmrEF的缺铁患者,可以考虑静脉注射铁,以改善生活质量.
- 对于心力衰竭患者,建议在住院期间及早启动指导方针导向的药物治疗,并及时进行出院后的随访.
结论:
- 更新的指南反映了心力衰竭管理的重大转变,扩大了HFmrEF和HFpEF人群的治疗选择.
- 药理干预措施,如SGLT2抑制剂和finerenone,以及支持性疗法,如铁,提供更好的结果和生活质量.
- 对心力衰竭管理采取全面的,以指导方针为导向的方法,从医院开始,持续到出院后,对于优化患者护理至关重要.
更多相关视频
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Heart Failure Drugs: Diuretics
381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381
Heart Failure Drugs: β-Blockers
340
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
340
Heart Failure Drugs: Inotropic Agents
588
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
588
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K


